Efficient B Cell Depletion via Diphtheria Toxin in CD19-Cre/iDTR Mice
Open Access
- 27 March 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e60643
Abstract
B cells were first discovered as antibody producing cells, as B-1 B cells and finally as effector cells. In recent years their capacity to serve as antigen presenting cells is increasingly appreciated, and better tools are needed to study their function. We have previously described a new mouse model, the iDTR mice, that allow for the Cre-mediated expression of the diphtheria toxin receptor, thus rendering cells that express the Cre-recombinase sensitivity to diphtheria toxin. Herein we describe a new mouse line, the B-DTR mice, where the CD19-Cre was crossed to the iDTR mice. B-DTR allows for the efficient and cost-effective depletion of different B cell subpopulations, but only partially plasma cells. These mice can therefore be used to study the importance of B cells versus plasma cells in different immune responses and autoimmune diseases.Keywords
This publication has 31 references indexed in Scilit:
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disordersJournal of Neuroinflammation, 2011
- Toll-like receptor 7 (TLR7)–driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunityBlood, 2011
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunityAnnals of Neurology, 2010
- B‐cell targeted therapies in human autoimmune diseases: an updated perspectiveImmunological Reviews, 2010
- Rituximab for the Treatment of Non-Hodgkinʼs Lymphoma and Chronic Lymphocytic LeukaemiaDrugs, 2010
- First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trialBlood, 2008
- New tools to study the role of B cells in cytomegalovirus infectionsMedical Microbiology and Immunology, 2008
- B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic SclerosisThe American Journal of Pathology, 2006
- Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapyAutoimmunity Reviews, 2006